(Q33208378)

23 July 2017

1 reference

title

Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis (English)

1 reference

23 July 2017

Daniel Molin

1

1 reference

23 July 2017

publication date

1 January 2004

1 reference

Upsala Journal of Medical Sciences

23 July 2017

published in

1 reference

23 July 2017

volume

109

1 reference

23 July 2017

issue

3

1 reference

23 July 2017

page(s)

179-228

1 reference

On some Morbid Appearances of the Absorbent Glands and Spleen

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Thomas Hodgkin: social activist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Rare occurrence of classical Hodgkin's disease as a T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Prognostic factors in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Abundant expression of chemokines in malignant and infective human lymphadenopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Eosinophil Predominance in Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

A quantitative study of mast cells in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

The role of cytokines in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Localization of the guinea pig eosinophil major basic protein to the core of the granule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Mast cells, eosinophils and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Mechanism of membrane damage mediated by human eosinophil cationic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Inhibition of ongoing immunoglobulin production by eosinophil cationic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Eosinophil cationic protein inhibits immunoglobulin production and proliferation in vitro in human plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

The two faces of the mast cell

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Mast cells in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Reevaluation of prognostic significance of symptoms in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Characterization of single-nucleotide polymorphisms in coding regions of human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Epidemiology and histopathology of Hodgkin's disease in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Epidemiological study of Hodgkin's disease in Cuba and Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

The epidemiology of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Presentation of Hodgkin's disease as an endobronchial lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Early-stage Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

The disappearance of prognostic factors in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Twenty years of MOPP therapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Breast cancer after treatment of Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

A systematic overview of chemotherapy effects in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Thyroid Diseases after Treatment of Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Late medical complications and fatigue in Hodgkin's disease survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Establishment of an immature mast cell line from a patient with mast cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Establishment and characteristics of two unique cell lines from patients with lymphosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Hodgkin's disease: establishment and characterization of four in vitro cell lies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Monocytes, but not macrophages, produce the eosinophil cationic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Tumour-associated eosinophilia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

A quantitative study of eosinophil polymorphs in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Polymorphism of the eosinophil cationic protein-gene is related to the expression of allergic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Management of early stage Hodgkin's disease: the role of radiation therapy and/or chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Treatment outcome in Hodgkin's disease in patients above the age of 60: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F2000-1967-084

21 January 2018

Identifiers

DOI

10.3109/2000-1967-084

1 reference

23 July 2017

1 reference